ATHENA (Q4271842)
Jump to navigation
Jump to search
Project Q4271842 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ATHENA |
Project Q4271842 in Italy |
Statements
163,312.38 Euro
0 references
217,749.84 Euro
0 references
75.0 percent
0 references
ATENA SRL
0 references
IL PROGETTO ATENA - ADVANCED AND VIRTUALITY TECHNOLOGIES FOR HEALTHCARE INNOVATION SI DISPIEGA LUNGO DUE PRINCIPALI LINEE DI SVILUPPO, MIRATE ALLA DIMOSTRAZIONE COMPLETA IN AMBIENTE OPERATIVO REALE DI DUE DISPOSITIVI MEDICI E ALLA RELATIVA IMMISSIONE IN COMMERCIO. LA PRIMA LINEA DI SVILUPPO CONCERNE UNA SEDUTA ADATTABILE PER UN SISTEMA INTELLIGENTE PER IL SUPPORTO ALLE TERAPIE DI RIABILITAZIONE DEI PAZIENTI CON DISTURBI NEURO-MOTORI (CONCESSIONE BREVETTO N. 202017000137884), LA SECONDA LINEA DI SVILUPPO RIGUARDA UN CASCHETTO MULTISENSORIALE PER UN SISTEMA DI MONITORAGGIO E SUPPORTO ALLA TERAPIA PER BAMBINI CON DISTURBI DEL NEURO-SVILUPPO, COME AUTISMO E PATOLOGIE AFFINI (CONCESSIONE BREVETTO N. 202018000002071). (Italian)
0 references
THE ATENA — ADVANCED AND VIRTUALITY TECHNOLOGIES FOR HEALTHCARE INNOVATION PROJECT DEVELOPS ALONG TWO MAIN LINES OF DEVELOPMENT, AIMED AT THE COMPLETE DEMONSTRATION IN THE REAL OPERATING ENVIRONMENT OF TWO MEDICAL DEVICES AND THEIR MARKETING. THE FIRST LINE OF DEVELOPMENT CONCERNS AN ADAPTABLE SEAT FOR AN INTELLIGENT SYSTEM TO SUPPORT REHABILITATION THERAPIES OF PATIENTS WITH NEURO-MOTOR DISORDERS (PATENT GRANT NO 202017000137884), THE SECOND LINE OF DEVELOPMENT CONCERNS A MULTISENSORY HELMET FOR A MONITORING AND TREATMENT SUPPORT SYSTEM FOR CHILDREN WITH NEURO-DEVELOPMENT DISORDERS, SUCH AS AUTISM AND RELATED DISEASES (PATENT CONCESSION NO 202018000002071). (English)
2 February 2022
0 references
LE PROJET ATENA — TECHNOLOGIES AVANCÉES ET VIRTUALITÉ POUR L’INNOVATION DANS LE DOMAINE DE LA SANTÉ SE DÉVELOPPE SELON DEUX GRANDES LIGNES DE DÉVELOPPEMENT, VISANT À LA DÉMONSTRATION COMPLÈTE DANS L’ENVIRONNEMENT DE FONCTIONNEMENT RÉEL DE DEUX DISPOSITIFS MÉDICAUX ET LEUR COMMERCIALISATION. LA PREMIÈRE LIGNE DE DÉVELOPPEMENT CONCERNE UN SIÈGE ADAPTABLE POUR UN SYSTÈME INTELLIGENT DE SOUTIEN AUX THÉRAPIES DE RÉADAPTATION DES PATIENTS ATTEINTS DE TROUBLES NEUROMOTEURS (OCTROI DE BREVET NO 202017000137884), LA DEUXIÈME LIGNE DE DÉVELOPPEMENT CONCERNE UN CASQUE MULTISENSORIELLE POUR UN SYSTÈME DE SUIVI ET DE TRAITEMENT POUR LES ENFANTS ATTEINTS DE TROUBLES NEURO-DÉVELOPPEMENT, TELS QUE L’AUTISME ET LES MALADIES CONNEXES (CONCESSION DE BREVET NO 202018000002071). (French)
3 February 2022
0 references
CERCOLA
0 references